Health TrialsbyHealthPanel

Culturally Adapted Contingency Management

ConditionStimulant Use Disorders
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorYale University

About this trial

The purpose of this study is to develop a culturally adapted contingency management (CM) protocol for Black adults with stimulant use disorder.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

participants must self-identify as Black/African American

DSM-5 diagnosis of stimulant use disorder in the past month (30 days)

Disqualifiers

individuals who are intoxicated or otherwise unable to provide consent

Trial design

Design model

Parallel

Treatments tested in this trial

  • Cultually Adapted Contingency Management (CM)

    Behavioral

    Same protocol as basic CM with adaptations incorporated. The adaption will involve the ADAPT-ITT framework and PEN-3 cultural model.

  • Basic Contingency Management (CM)

    Behavioral

    An escalating schedule of reinforcement for submitting stimulant-negative urine at each clinic visit over the course of the 12 weeks

Treatment groups

70 Participants
are divided into 3 treatment groups
Group A: Culturally Adapted CMExperimental treatment 1 intervention
Group B: Basic CMExperimental treatment 1 intervention
Group C: Standard Care ConditionNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Percent negative urine samples

Participants will provide urine samples twice weekly. Percent of negative urines provided will be calculated.

Time frame
Week 12
2

Mean longest duration of abstinence

The longest duration of abstinence in days will be measured.

Time frame
Week 12

Secondary outcomes

1

Mean treatment retention

Treatment retention in days will be measured.

Time frame
Baseline and Week 12.
2

Acceptability of Intervention Measure (AIM)

Treatment Acceptability will be measured using the Acceptability of Intervention Measure (AIM), a 4-item measure of perceived intervention acceptability.Total score 1-5 with higher scores indicating greater acceptability.

Time frame
Week 12
3

Feasibility of Intervention Measure (FIM)

Feasibility of intervention measured using Feasibility of Intervention Measure (FIM)- a 4-item instrument to assess perceived intervention feasibility. Total score 1-5 with higher scores indicating greater feasibility.

Time frame
Week 12
4

Client Satisfaction Questionnaire (CSQ-8)

An 8-item, self-report measure developed to assess global satisfaction with health and behavioral health services. Each item is rated on a 4-point Likert scale, producing total scores ranging from 8 to 32, with higher scores indicating greater satisfaction. The instrument evaluates perceived quality of care, extent to which services met the client's needs, overall benefit, and willingness to recommend the service

Time frame
Week 12

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Yale University

Lead sponsor

National Institute on Drug Abuse (NIDA)

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: